These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27885202)

  • 1. [SUBLINGUAL IMMUNOTHERAPY FOR MITE ALLERGIC RHINITIS].
    Okamoto Y
    Arerugi; 2016; 65(9):1187-1191. PubMed ID: 27885202
    [No Abstract]   [Full Text] [Related]  

  • 2. [YEAR IN REVIEW OF NASAL ALLERGY: SUBLINGUAL IMMUNOTHERAPY].
    Masuyama K
    Arerugi; 2015 Sep; 64(9):1210-4. PubMed ID: 26657909
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE OFFICIAL HAND BOOK FOR ALLERGEN IMMUNOTHERAPY IN MITE-ALLERGY - CAUSAL TREATMENT FOR PERENNIAL ALLERGIC AIRWAY DISEASES].
    Nagata M
    Arerugi; 2016 Jul; 65(7):908-12. PubMed ID: 27545055
    [No Abstract]   [Full Text] [Related]  

  • 4. Sublingual immunotherapy in patients with house dust mite allergic rhinitis: prospective study of clinical outcomes over a two-year period.
    Soh JY; Thalayasingam M; Ong S; Loo EX; Shek LP; Chao SS
    J Laryngol Otol; 2016 Mar; 130(3):272-7. PubMed ID: 26781592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report.
    Li JT; Bernstein DI; Calderon MA; Casale TB; Cox L; Passalacqua G; Pfaar O; Papadopoulos NG
    J Allergy Clin Immunol; 2016 Feb; 137(2):369-76. PubMed ID: 26371843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of sublingual immunotherapy on Th2 type immunoreaction in patients with allergic rhinitis].
    Meng Q; Liang Y; Zhang W; Xie J; Su F; Yang Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):90-3. PubMed ID: 24738309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual or subcutaneous immunotherapy for allergic rhinitis?
    Durham SR; Penagos M
    J Allergy Clin Immunol; 2016 Feb; 137(2):339-349.e10. PubMed ID: 26853126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on house dust mite immunotherapy: are more studies needed?
    Nelson HS
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):542-8. PubMed ID: 25115684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy in children: the recent experiences.
    Pleskovic N; Bartholow A; Skoner DP
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):582-90. PubMed ID: 25188717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.
    Nolte H; Maloney J; Nelson HS; Bernstein DI; Lu S; Li Z; Kaur A; Zieglmayer P; Zieglmayer R; Lemell P; Horak F
    J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Sublingual Immunotherapy with Dermatophagoides farinae Extract in Monosensitized and Polysensitized Patients with Allergic Rhinitis: Clinical Observation and Analysis.
    Xu CX; Zhang ML; Li BZ; He Y; Zou ZH; Wu QR; Tao AL; Lai H; Sun JL
    Biomed Res Int; 2015; 2015():187620. PubMed ID: 26000283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites.
    Maloney J; Prenner BM; Bernstein DI; Lu S; Gawchik S; Berman G; Kaur A; Li Z; Nolte H
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):59-65. PubMed ID: 26553448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained improvement of psoriatic lesions in the course of sublingual immunotherapy for airborne allergens: clinical evidence of cross-tolerance.
    Theodoropoulos DS; Morris MS; Morris DL
    Eur Rev Med Pharmacol Sci; 2015; 19(3):392-5. PubMed ID: 25720708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
    Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
    J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual immunotherapy in children.
    Tortajada-Girbés M; Rivas-Juesas C
    Allergol Immunopathol (Madr); 2018; 46(2):105-106. PubMed ID: 29458988
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases.
    Li P; Li Q; Huang Z; Chen W; Lu Y; Tian M
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):796-801. PubMed ID: 25145986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis.
    Demoly P; Okamoto Y; Yang WH; Devillier P; Bergmann KC
    Expert Rev Clin Immunol; 2016 Nov; 12(11):1141-1151. PubMed ID: 27632814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient for Long-term Benefit?
    Cox LS
    JAMA; 2017 Feb; 317(6):591-593. PubMed ID: 28196239
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunotherapy for allergic rhinitis].
    Yuta A
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Feb; 118(2):152-5. PubMed ID: 26506624
    [No Abstract]   [Full Text] [Related]  

  • 20. Is Sublingual Immunotherapy an Effective Therapy for Allergic Rhinitis?
    Ahmed OG; Lane AP
    Laryngoscope; 2020 Oct; 130(10):2301-2302. PubMed ID: 32068887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.